Literature DB >> 25461464

Prevalence of constipation among the general population: a community-based survey from India.

Mamta Rajput1, Sushma Kumari Saini.   

Abstract

Constipation is a frequent health problem leading to great discomfort to the person and affects his or her quality of life. It is considered to be highly prevalent in the general population, but there is little data supporting the findings. This study was undertaken with an objective to assess the prevalence of constipation and its associated factors among the general population of Dadu Majra Colony, UT, Chandigarh, India. A total of 505 individuals were interviewed through structured questionnaire based on ROME II criteria for constipation. Results revealed that the prevalence of self-reported constipation within the last 1 year was 24.8% whereas 16.8% of participants had constipation according to the Rome II criteria. Most of the subjects (83%) were within the age group of 18-59 years with mean age (years) of 38.64 ± 15.57. Constipation was significantly more frequent in females than in males (20% vs. 13%) and in nonworking population than in working population (20% vs. 12%). Poor dietary habits, lesser fluid intake per day, and lesser physical activity were found to be significant factors leading to the constipation. About 18% of constipated subjects reported physicians' consultation, whereas 8% reported the use of laxatives to relieve their constipation.

Entities:  

Mesh:

Year:  2014        PMID: 25461464     DOI: 10.1097/SGA.0000000000000074

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  9 in total

Review 1.  Chronic constipation in Rome IV era: The Indian perspective.

Authors:  Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2017-06-23

2.  Evaluation of the Symptom of Constipation in Indian Patients.

Authors:  Gautam Ray
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 3.  Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.

Authors:  M Masudur Rahman; Sanjiv Mahadeva; Uday C Ghoshal
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

Review 4.  Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.

Authors:  Paula Mosińska; Hubert Zatorski; Martin Storr; Jakub Fichna
Journal:  J Neurogastroenterol Motil       Date:  2017-04-30       Impact factor: 4.924

5.  Prevalence of constipation among central region population, Riyadh and Qassim provinces, Saudi Arabia, 2018-2019.

Authors:  Mohammed Alhassan; Abdulaziz Alhassan; Abdulaziz Alfarhood; Khalid Alotaibi; Nashmi Alrashidy; Khalid Alshalhoub; Meshal Almeshal
Journal:  J Family Med Prim Care       Date:  2019-02

6.  Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.

Authors:  Jae Ryang Chu; Saem-Yi Kang; Sung-Eun Kim; Sol-Ji Lee; Young-Chul Lee; Mi-Kyung Sung
Journal:  World J Gastroenterol       Date:  2019-10-28       Impact factor: 5.742

7.  Constipation Risk in Patients Undergoing Abdominal Surgery.

Authors:  Sevim Celik; Nurdan Yalcin Atar; Nilgun Ozturk; Guler Mendes; Figen Kuytak; Esra Bakar; Duygu Dalgiran; Sumeyra Ergin
Journal:  Iran Red Crescent Med J       Date:  2015-06-23       Impact factor: 0.611

8.  Prevalence and Self-recognition of Chronic Constipation: Results of an Internet Survey.

Authors:  Akio Tamura; Toshihiko Tomita; Tadayuki Oshima; Fumihiko Toyoshima; Takahisa Yamasaki; Takuya Okugawa; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Hisatomo Ikehara; Yoshio Ohda; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

9.  Treatment Satisfaction With Current Medications for Chronic Constipation: An Internet Survey of Japanese Patients.

Authors:  Toshihiro Hayashi; Hiroto Miwa
Journal:  J Clin Gastroenterol       Date:  2022-01-01       Impact factor: 3.062

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.